Table 3 demonstrates the percentage of CD11b+CADO48A+ cell populations when gated on all live cells (R1), all myeloid non-lymphocyte cells (P1) and CD11b/CADO48A subpopulations (P2-P4) across individual tumor types (i.e. sarcoma, carcinoma and melanoma). Here, ITGAM is linked to carcinoma.